Q: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Constraint: The Compound has the SMILES CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1.[Cl-].
Result: Approved
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1.[Cl-]
CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1.[Cl-]
2-[(2-pyridin-1-ium-1-ylacetyl)amino]ethyl dodecanoate;chloride
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.